Despite data gaps in many countries, the burden of sickle cell disease, especially in west and central Africa, underscores the urgent need to scale up newborn and early childhood screening, ...

Precedence Research introduces its Advanced Cell and Gene Therapy Intelligence Platform, turning complex data into actionable ...

Novo Nordisk’s etavopivat elicited a 27% drop in vaso-occlusive crises and 48.7% hemoglobin response after 24 weeks, creating ...

Deck Bio, a biotechnology company advancing multi-pMHC targeted T cell engagers for solid tumors, today presented new preclinical data for its lead program, DBXO-1, at the American Association for ...

This past Friday, July 12th, 2025, MiNK Therapeutics (INKT) closed the day higher by 730% to $64.17 per share. The reason for this massive surge in stock price was because of the release of data from ...

A stem cell therapy with potential disease-modifying effects for feline osteoarthritis (OA) is underway.